Showing results (1551-1560 of 1,773) with videos related to

Sort By:
Pageof 178
American Journal of Cancer Research|November 18, 2024
Evodiamine exerts anti-cancer activity including growth inhibition, cell cycle arrest, and apoptosis induction in human follicular thyroid cancersHui-I Yu, Hong-Yi Chang, Chieh-Hsiang Lu, et al.
Cell Death & Disease|June 2, 2017
MiR-125b regulates proliferation and apoptosis of nasopharyngeal carcinoma by targeting A20/NF-κB signaling pathwayZhen Zheng, Jia-Quan Qu, Hong-Mei Yi, et al.
Acta Pharmacologica Sinica|September 22, 2017
The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysisYing Xue, Zhi-Wei Feng, Xiao-Ye Li, et al.
Carcinogenesis|May 26, 2010
An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cellsHsiao-Sheng Liu, Pei-Yin Hsu, Ming-Derg Lai, et al.
Scientific Reports|February 25, 2017
Accelerated disease progression and robust innate host response in aged SIVmac239-infected Chinese rhesus macaques is associated with enhanced immunosenescenceHong-Yi Zheng, Ming-Xu Zhang, Min Chen, et al.
Journal of Medicinal Chemistry|February 17, 2026
Design, Synthesis, and Antitumor Evaluation of Benzamide Derivatives Targeting HOXA1 FunctionYong-Jian Wang, Xiao-Ning Yang, Feng Wang, et al.
The American Journal of Pathology|January 10, 2014
The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytesQian Zhang, Fang Wei, Hong Yi Wang, et al.
CNS Neuroscience & Therapeutics|December 13, 2022
Variants in BRWD3 associated with X-linked partial epilepsy without intellectual disabilityMao-Qiang Tian, Xiao-Rong Liu, Si-Mei Lin, et al.
Nano Letters|January 18, 2013
Phase separation induced by Au catalysts in ternary InGaAs nanowiresYa-Nan Guo, Hong-Yi Xu, Graeme J Auchterlonie, et al.
Carcinogenesis|April 9, 2013
The PML isoform IV is a negative regulator of nuclear EGFR's transcriptional activity in lung cancerHong-Yi Kuo, Yi-Chen Chen, Hsiang-Yi Chang, et al.
Pageof 178